EverSource Wealth Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History

EverSource Wealth Advisors’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18	Closed	-$70	–	4503
2026 Q1	$70	Sell	18 -31	-63%	-$76	﹤0.01%	4300
2025 Q4	$96	Sell	49 -180	-79%	-$295	﹤0.01%	4110
2025 Q3	$193	Sell	229 -149	-39%	-$110	﹤0.01%	4116
2025 Q2	$274	Buy	378 +233	+161%	+$175	﹤0.01%	4011
2025 Q1	$124	Buy	145 +45	+45%	+$67	﹤0.01%	3787
2024 Q4	$168	Buy	+100	New	+$239	﹤0.01%	3465
2023 Q2	–	Sell	-633	Closed	-$1.75K	–	2561
2023 Q1	$1.75K	Buy	+633	New	+$1.33K	﹤0.01%	1973

Other funds holding NAUT

Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return

Hillman Company Pittsburgh, Pennsylvania $283M AUM 23.82% 1-Year Est. Return

Crewe Advisors Salt Lake City, Utah $1.38B AUM 41.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

ATPW

Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

PCM

Presidio Capital Management San Diego, California $400M AUM 22.73% 1-Year Est. Return

BPWM

Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

EverSource Wealth Advisors's NAUT Position: Q2 2026 in Review

EverSource Wealth Advisors sold out of Nautilus Biotechnolgy (NAUT) in Q2 2026, closing a stake of 18 shares — an estimated $70 sold.

EverSource Wealth Advisors first reported a position in NAUT in Q1 2023 and held it in 7 quarters. The position peaked at $1.75K in Q1 2023. 18 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

EverSource Wealth Advisors reported no remaining Nautilus Biotechnolgy position as of Q2 2026 after selling out during the quarter.
EverSource Wealth Advisors sold 18 Nautilus Biotechnolgy shares in Q2 2026, an estimated $70.
EverSource Wealth Advisors first reported a position in Nautilus Biotechnolgy in Q1 2023 and held it in 7 quarters.
EverSource Wealth Advisors's Nautilus Biotechnolgy position peaked at $1.75K in Q1 2023.
18 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.